Subscribe To
Silverbow is an excellent candidate for trend investing with 94% accuracy
SilverBow Resources Inc. (NYSE:SBOW) gained 16.92% this week. The stock has been gaining since oil and gas prices began rising....
May 28, 2022, 4:51 pm
Mirati (mrtx) down 23% on mixed data from lung cancer study
Mirati (MRTX) posts positive data from a phase II study evaluating its lung cancer candidate adagrasib....
May 27, 2022, 3:49 pm
Iovance (iova) down after announcing data from melanoma study
Results from a cohort of the phase II study evaluating Iovance's (IOVA) melanoma candidate were not as ...
May 27, 2022, 3:49 pm
4d pharma outlines phase ii plans for promising cancer drug candidate
4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) will deliver what's called a ‘trial in progress' poster at a world-leading cancer conference outlining the pla...
May 27, 2022, 2:50 am
Poolbeg pharma hails us patent office success; says it marks an important step towards commercialising assets
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said it had been granted US patents protecting two key assets – POLB 001, a potential flu treatment, and ...
May 26, 2022, 2:40 am
Springworks (swtx) down despite desmoid tumors study meeting goal
SpringWorks' (SWTX) phase III study evaluating its investigational candidate, nirogacestat, in adult pa...
May 25, 2022, 1:48 pm
Disney: one key change should be made
Disney+ is growing rapidly and ESPN+ is nothing to laugh at, but Hulu cannot seem to keep up with its competitors. Many investors are calling for Disn...
May 25, 2022, 2:31 am
5 short squeeze candidates to watch this week: 2 former spacs join leaderboard with bigbear.ai topping list
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
May 24, 2022, 11:32 am
Immunogen (imgn) ovarian cancer drug bla gets priority review
ImmunoGen (IMGN) gets priority review from the FDA for the BLA seeking approval for its lead candidate,...
May 24, 2022, 11:18 am
Recruiter.com unveils new candidate tracking capabilites in a suite of ai updates
Recruiter.com Group Inc. has updated its artificial intelligence recruiting software platform to improve search capacity, email outreach and ...
May 24, 2022, 9:59 am
Apple: strong investment candidate revealed by fama french
Underneath its tech surface, Apple is a quintessential example of value investing. A simplified Fama French scorecard reveals its astronomical profita...
May 23, 2022, 4:55 pm
Mirati (mrtx) seeks eu nod for adagrasib to treat lung cancer
Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory f...
May 20, 2022, 3:48 pm
Nkarta: a promising natural killer cell play
The market has favorably appreciated Nkarta's recent readout of its NKX101 and NKX019 drug candidates, ...
May 20, 2022, 3:14 pm
Wells fargo held bogus interviews with minority candidates for jobs already filled: new york times
Six current and former employees at Wells Fargo & Co.'s large wealth management unit said they were encouraged to interview women and African American...
May 20, 2022, 11:08 am
Immuneering announces participation in upcoming investor conferences
CAMBRIDGE, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ: IMRX), a biopharmaceutical company using translational bioinform...
May 20, 2022, 6:50 am
Moleculin to present at the h.c. wainwright global investment conference
HOUSTON, May 19, 2022 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical comp...
May 19, 2022, 8:05 am
Veru inc. still has serious growth to realize
Veru Inc is a Florida-based drug developer, which focuses primarily on developing cancer-treatment drugs as well as its sexual health division. This y...
May 19, 2022, 3:41 am
Argenx se: again following dutch biotech, prior recommendation near-term gain
Derivatives markets, used by the market-making community to hedge equity market liquidity trade orders, tell by their component structure and prices t...
May 18, 2022, 2:38 pm
Ultragenyx (rare) acquires rights of aav gene therapy candidate
Ultragenyx (RARE) signs an exclusive license agreement with Abeona Therapeutics to acquire the latter's gene therapy ...
May 18, 2022, 1:32 pm
Acasti pharma's iv hemorrhage drug candidate at par with oral nimodipine
Acasti Pharma Inc's (NASDAQ: ACST) pharmacokinetic (PK) bridging study with IV GTX-104, its lead drug candid<...
May 18, 2022, 11:28 am